In This Section

SABCS 2021 Press Program

The San Antonio Breast Cancer Symposium (SABCS) official press program included a virtual press conference featuring four newsworthy studies from the symposium. The press program also included news releases on four additional abstracts.

PRESS CONFERENCE

The AACR communications team hosted a virtual press conference on Monday, December 6 at 2:30 p.m. CT. SABCS Co-Directors Virginia Kaklamani, MD, and Carlos Arteaga, MD, FAACR, moderated the event.

View the Press Conference


The following studies were presented:

Using Genomics to Match Treatments Improved Outcomes for Certain Patients With Metastatic Breast Cancer

  • Presented by Fabrice André, MD, PhD, Gustave Roussy

Elacestrant May Improve Outcomes for Patients Whose Metastatic Breast Cancers Progressed on Prior Endocrine Therapy

  • Presented by Aditya Bardia, MD, MPH, Massachusetts General Hospital Cancer Center

Breast Cancer Patients with Estrogen Receptor Mutations May Benefit From Early Switch to Fulvestrant/Palbociclib

  • Presented by François-Clément Bidard, MD, PhD, Institut Curie

Black Women are More Likely to Develop Lymphedema Following Breast Cancer Treatment than White Women

  • Presented by Andrea V. Barrio, MD, Memorial Sloan Kettering Cancer Center

ADDITIONAL News releases

Single-cell Spatial Analysis May Help Predict Response to Neoadjuvant Immunotherapy in Triple-negative Breast Cancer

  • Presented by Giampaolo Bianchini, MD, IRCCS Ospedale San Raffaele

Tamoxifen May Boost PI3K Signaling to Increase Uterine Cancer Risk in Patients With Breast Cancer

  • Presented by Kirsten Kübler, MD, PhD, Broad Institute of MIT and Harvard

Investigational Therapy Pyrotinib with Chemotherapy May Improve Outcomes in Patients with Pretreated HER2-positive Breast Cancer

  • Presented by Binghe Xu, MD, PhD, Chinese Academy of Medical Sciences

Black and White Women Who Received Neoadjuvant Therapy Were Equally Likely to Have Pathologic Complete Response

  • Presented by Beverly Kyalwazi, BS, University of Chicago Pritzker School of Medicine